Skip to content

Therapeutic efficacy of laser therapy (carbon dioxide laser)with intralesional steroid injection versus cold therapy (cryotherapy) with intralesional steroid injection in the treatment of keloidal scar:a randomized controlled trial.

Therapeutic efficacy of intralesional steroids with carbon dioxide laser versus with cryotherapy in treatment of keloids: a randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/01/005400
Enrollment
60
Registered
2015-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Keloid with less than or equal to 5 cms and 5 in number

Interventions

Intervention1: intralesional steroids with carbon dioxide laser: carbon dioxide laser at baseline followed by intralesional steroid for 3 months at 1 month interval Intervention2: laser with intrales

Sponsors

JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the cases of keloids irrespective of gender, site of involvement, duration of lesions to be included in the study if they are 1. Keloid of size 2. Multiple keloids

Exclusion criteria

Exclusion criteria: 1. Age less than 12 years 2. Pregnant and lactating women. 3. Keloids with concomitant infection. 4. Coexisting inflammation in adjacent skin secondary to dermatological diseases (such as psoriasis, lichen planus, eczemas, etc.) 5. Patients with unrealistic expectations or psychiatric illnesses. 6. Preexisting bleeding disorder, renal or hepatic diseases

Design outcomes

Primary

MeasureTime frame
To compare the therapeutic efficacy of combination of carbon dioxide laser followed by intralesional triamcinolone acetonide versus cryotherapy followed by intralesional triamcinolone acetonide in treatment of keloids.Timepoint: 3, 6, 12 months

Secondary

MeasureTime frame
To study the recurrence rate following treatment with these two different combination therapies. Timepoint: 12 months

Countries

India

Contacts

Public ContactBiswanath Behera

JIPMER

rashmi.sreerag@gmail.com09489692199

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026